As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...